Skip to content

Ovarian PRP Injection in Women With POR

Effect of Ovarian Injection of Autologous Platelet-Rich Plasma on the Pregnancy Outcome of IVF/ICSI in Patients With Poor Ovarian Response: A Prospective Randomized Controlled Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05601193
Enrollment
390
Registered
2022-11-01
Start date
2022-10-27
Completion date
2025-10-31
Last updated
2022-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Poor Ovarian Response

Keywords

Poor Ovarian Response; Platelet-Rich Plasma

Brief summary

Patients with poor ovarian response (POR)is considered one of most challenging tasks in artificial reproductive treatment (ART). Several retrospective studies have shown that platelet-rich plasma (PRP) is one of the proposed therapeutic strategies for women with POR. However, prospective randomized controlled trials are still lacking. This study aimed to evaluate the effect on intraovarian injection of autologous PRP in poor ovarian reserve prospectively.

Detailed description

It will be divided two groups of POR patients according to the treatment itself. One group was treated by intraovarian injection of autologous PRP, and the other was control. It will detect the function of ovarian reserve and IVF outcomes before and after treatment in both two groups. In addition, granulosa cells and follicular fluid before and after injection were collected for functional exploration experiments.

Interventions

autologous PRP preparation was done by segregation of PRP following the centrifugation

Sponsors

Sixth Affiliated Hospital, Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 43 Years
Healthy volunteers
No

Inclusion criteria

* 1\) Women less than 43 years old and undergo IVF/ICSI; 2) AMH \< 1.1 and the number of follicles in bilateral antrum \< 7; 3) those who have obtained less than or equal to 3 follicles in conventional controlled ovulation cycle or whose diameter ≥ 14mm on the trigger day; or have a previous history of ovarian cyst removal; if the woman is less than 40 years old, she needs to meet the inclusion criteria 2 and 3 at the same time. If you are 40 years old or older, you can join the group if you meet the inclusion criteria 2 or 3.

Exclusion criteria

* 1\) patients with clear indications or plans to undergo pre-embryo transfer genetic diagnosis (PGD) and preimplantation genetic screening (PGS); 2) patients with recurrent abortion who had more than 2 consecutive spontaneous abortions (including biochemical pregnancy); 3) men with azoospermia who underwent microsemen extraction; 4) benign ovarian cysts (endometriosis cyst, teratoma, etc.) found by B-ultrasound; 5) women with heart, liver and kidney insufficiency. 6) one of the husband and wife has chromosome abnormality; 7) the history of malignant tumor of the woman or the hereditary family history of the husband and wife 8) uterine anatomical abnormalities (including uterine adhesion, endometrial polyps, submucous myoma, uterine mediastinum, etc.) 9) untreated hydrosalpinx 10) uncontrolled endocrine abnormalities, including thyroid dysfunction, diabetes, etc. 11) other reasons that the researchers believe are not appropriate to participate in this study, such as positive for syphilis or HIV.

Design outcomes

Primary

MeasureTime frameDescription
number of oocytes retrieval2 yearsThe number of oocytes retrieval under the same ovarian stimulation protocol before and after PRP injection

Secondary

MeasureTime frameDescription
Ovarian function in DOR patients before and after PRP injection.2 yearsAnti-müllerian Hormone (AMH) serum level, Follicle Stimulating Hormone (FSH) serum level, Estradiol (E2) serum level level on menstrual day 2/3
Outcomes of IVF in DOR patients before and after PRP injection under the same ovarian stimulation protocol.3 yearsThe number of oocyte retrieval, fertilization rate , blastocyst formation rate, implantation rate, incidence of clinical pregnancy rate

Other

MeasureTime frameDescription
Functional experiments of follicular fluid and granulosa cells before and after PRP injection1 yearChanges of hormone/ RNA/ protein / growth factor expression in follicular fluid and granulosa cells before and after PRP injection

Countries

China

Contacts

Primary ContactXiaoyan Liang
liangxy2@mail.sysu.edu.cn86 020-38250752
Backup ContactQian Li
liqian226@126.com15917369026

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026